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Original articleAlterations in hypothalamic gene expression
following Roux-en-Y gastric bypassPernille Barkholt 1,2,*, Philip J. Pedersen 1, Anders Hay-Schmidt 2, Jacob Jelsing 1, Henrik H. Hansen 1,
Niels Vrang 1ABSTRACT
Objective: The role of the central nervous system in mediating metabolic effects of Roux-en-Y gastric bypass (RYGB) surgery is poorly un-
derstood. Using a rat model of RYGB, we aimed to identify changes in gene expression of key hypothalamic neuropeptides known to be involved in
the regulation of energy balance.
Methods: Lean male Sprague-Dawley rats underwent either RYGB or sham surgery. Body weight and food intake were monitored bi-weekly for
60 days post-surgery. In situ hybridization mRNA analysis of hypothalamic AgRP, NPY, CART, POMC and MCH was applied to RYGB and sham
animals and compared with ad libitum fed and food-restricted rats. Furthermore, in situ hybridization mRNA analysis of dopaminergic trans-
mission markers (TH and DAT) was applied in the midbrain.
Results: RYGB surgery signiﬁcantly reduced body weight and intake of a highly palatable diet but increased chow consumption compared with
sham operated controls. In the arcuate nucleus, RYGB surgery increased mRNA levels of orexigenic AgRP and NPY, whereas no change was
observed in anorexigenic CART and POMC mRNA levels. A similar pattern was seen in food-restricted versus ad libitum fed rats. In contrast to a
signiﬁcant increase of orexigenic MCH mRNA levels in food-restricted animals, RYGB did not change MCH expression in the lateral hypothalamus.
In the VTA, RYGB surgery induced a reduction in mRNA levels of TH and DAT, whereas no changes were observed in the substantia nigra relative
to sham surgery.
Conclusion: RYGB surgery increases the mRNA levels of hunger-associated signaling markers in the rat arcuate nucleus without concomitantly
increasing downstream MCH expression in the lateral hypothalamus, suggesting that RYGB surgery puts a brake on orexigenic hypothalamic
output signals. In addition, down-regulation of midbrain TH and DAT expression suggests that altered dopaminergic activity also contributes to the
reduced intake of palatable food in RYGB rats.
 2016 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Obesity, diabetes and the metabolic syndrome are major health
problems worldwide. The World Health Organization estimates that
more than 1.9 billion adults and over 42 million children under the age
of ﬁve are overweight or obese [1]. With today’s epidemic proportions
of obesity, more deaths are related to overweight than underweight.
Lifestyle intervention and pharmacological treatment have had limited
success in weight management in obese patients [2,3]. Hence, to date
bariatric surgery procedures, including Roux-en-Y gastric bypass
(RYGB), are considered the most effective treatment of obesity and its
co-morbidities, such as type-2 diabetes mellitus (T2DM), hypertension
and stroke [4,5].
The exact mechanisms underlying the weight loss and anti-diabetic
effects of gastric bypass are not fully understood, and substantial ef-
forts are being made to identify novel targets for more efﬁcacious anti-
obesity drug therapies. One of the consistent ﬁndings in animal models
as well as in humans after RYGB is elevated plasma levels of gut-1Gubra, Agern Alle 1, 2970 Hørsholm, Denmark 2Department of Neuroscience and Phar
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tide YY (PYY), and it is believed that these hormones are involved in the
beneﬁcial effects of surgery [6e9]. However, despite the intense
research into the underlying mechanisms of RYGB-induced weight
loss, currently, there is a lack of studies speciﬁcally investigating the
changes in central signaling pathways involved in metabolic control. It
is well-known that long-term energy balance is regulated by a complex
network of central signaling pathways that regulate food intake, energy
expenditure and metabolic efﬁcacy [10]. Essential for weight homeo-
stasis is the integration of orexigenic and anorexigenic signaling by the
leptin and melanocortin dependent pathways within the central ner-
vous system (CNS) [11]. The hypothalamic arcuate nucleus (Arc) is of
special importance, as this region contains two distinct leptin
responsive neuronal populations, i.e. orexigenic neuropeptide Y (NPY)
and agouti-related peptide (AgRP) expressing neurons as well as
anorexigenic cocaine and amphetamine related transcript (CART) and
proopiomelanocortin (POMC) expressing neurons [12e14]. These ﬁrst
order neurons in the Arc project to the paraventricular nucleus (PVN)macology, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen N, Denmark
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and the lateral hypothalamus (LHA), which, in combination, determine
the balance of behavioral and autonomic outputs involved in eating
behavior and metabolism (For review see [14]). Present information on
transcriptional changes in the Arc following bariatric surgery is limited
to a few studies assessing the effects of biliopancreatic and duodenal-
jejunal bypass in rats. Interestingly, both procedures were shown to
signiﬁcantly increase the arcuate NPY expression, indicating that
orexigenic pathways were stimulated without neutralizing the surgi-
cally induced reductions in food intake and body weight [15,16]. This
counterintuitive response indicates that other downstream signaling
cascades may be blocked, potentially MCH expression in the LHA,
which is known to be strongly modulated by POMC (inhibition) and NPY
(activation) application [12].
Besides the homeostatic regulation of energy balance, central hedonic
signaling is also able to inﬂuence whole body energy homeostasis [17].
In accordance, the mesolimbic dopaminergic pathway is closely
associated with the regulation of food intake where elevated levels of
dopamine in the ventral tegmental area (VTA) causes increased
motivation to consume particularly energy-dense food [18]. This may
also be relevant for the weight lowering effect of gastric bypass pro-
cedures, as rodent RYGB models are reported to change food pref-
erence from high to low sweet and fat food stimuli [19e21], indicating
that RYGB modiﬁes the hedonic value of energy-dense food. To date,
however, very few studies have investigated the central component of
this altered behavior on the transcriptional level.
The present study was undertaken to get further insight into the central
signaling pathways potentially inﬂuenced by RYGB surgery. A special
emphasis was put on key relay structures conveying orexigenic and
anorexigenic signaling in the hypothalamus, including the Arc and LHA.
In addition, to investigate neural circuitries underlying the interaction
between nutritional status and reward, the impact of RYGB on tran-
scriptional markers of midbrain dopaminergic neurotransmission was
assessed.
2. MATERIALS AND METHODS
2.1. Experimental animals
All animal experiments were conducted in accordance with interna-
tionally accepted principles for the care and use of laboratory animals,
and in compliance with personal animal license (2013-15-2934-
00784) issued by the Danish Committee for Animal Research.
Male Sprague Dawley rats 12 weeks of age underwent either RYGB
(n¼ 9; body weight 409 16 g) or sham surgery (n¼ 9; body weight
360  7 g). Four weeks prior to surgery, animals had ad libitum ac-
cess to a two-choice diet consisting of chow (altromin 1324, Bro-
gaarden, Denmark) and the Gubra high palatable high fat diet (HPHF
diet; Nutella (Ferrero, Italy), peanut butter (pcd, Netherlands) and
powdered chow [22]). The rats were single-housed throughout the
study under controlled environmental conditions (12 h light/12 h dark
cycle; 22  1 C; 50  10% relative humidity). Body weight, food and
water intake were monitored bi-weekly during the study.
In addition, male Sprague Dawley rats were included as food restricted
(n ¼ 8) and free-fed (n ¼ 8) controls for the analysis of hunger vs.
satiety associated hypothalamic gene expression. Free-fed animals
had ad libitum access to the two-choice diet as described above,
whereas food restricted animals had access to approximately 50% of
the food ingested by free-fed animals. Animals were terminated by
decapitation under CO2/O2 anesthesia after 48 h, and brains were
quickly removed and snap frozen on crushed dry ice and stored
at 80 C until further processing.MOLECULAR METABOLISM 5 (2016) 296e304  2016 The Authors. Published by Elsevier GmbH. This is an op
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Three days prior to surgery, animals were put on liquid diet (Osmolite 1
Cal.; Abbott Nutrition). On the day of surgery, animals underwent whole
body composition analysis by non-invasive EchoMRI scanning
(EchoMRI-900 Analyzer, EchoMRI, USA), and a wire grate was placed
in the bottom of the cage to prevent coprophagia. Prior to surgery,
animals were subcutaneously administered with warm saline (20 ml/
kg), buprenorphine (0.03 mg/kg), enroﬂoxacin (0.5 mg/kg) and car-
profen (0.5 mg/kg) to prevent post-operative infection, lethargy and
pain relief.
The RYGB surgical procedure was performed according to Chambers
et al. [23]. In brief, the abdomen was exposed using a midline lapa-
rotomy after induction of surgical anesthesia with an isoﬂurane/O2
mixture. The jejunum was transected 30 cm distal to the ligament of
Treitz. A longitudinal anti-mesenteric incision was made 10 cm distal
to the transected bowel and connected to the afferent limb of the
jejunum with a running 8-0 Vicryl absorbable suture (Ethicon, Som-
erville, NJ, USA). The stomach was exposed and the fundus was
excised by making a vertical cut along the line separating the corpus
from the fundus with an ETS-FLEX 35-mm staple gun (Ethicon). A
second staple line was placed across the waist of the stomach,
creating a gastric pouch approximately 10% the size of the normal
stomach. The distal remnant was returned to the peritoneal cavity and
an incision was made on one side of the gastric pouch considering the
vascular architecture. The efferent limb of the transected jejunum was
connected to the gastric pouch with a running 8-0 nylon non-
absorbable suture (Ethicon). After repositioning the gastric pouch
into the peritoneal cavity, the abdominal wall was closed.
The sham procedure followed the steps of the RYGB but gastrointes-
tinal surgery only included a transection of the jejunum 30 cm distal to
the ligament of Treitz, which was immediately re-sutured.
2.3. Post-surgery care
The wire grate was kept in place for ﬁve days post-operatively, and
only liquid diet was offered in this period. Subcutaneous injections of
warm saline BID (20 ml/kg), carprofen QD (5 mg/kg) and enroﬂoxacin
QD (5 mg/kg) were administered for ﬁve days after surgery. On day six,
the wire grate was removed and ad libitum access to the two-choice
diet was re-introduced.
2.4. Termination
60 days post-surgery, animals were euthanized by decapitation under
CO2/O2 anesthesia. All animals were euthanized in the morning, 2e3 h
after lights on. RYGB and sham operated animals were terminated in a
randomized order. Prior to termination, animals underwent an addi-
tional whole-body echo-MRI scan. Following termination, brains were
quickly removed, snap frozen on crushed dry ice, and stored
at 80 C until further processing.
2.5. Tissue processing
12 mm thick coronal sections of the hypothalamus and midbrain were
cut on a cryostat (CM 1850, Leica, Germany) using systematic uniform
random sampling. Serial sections were sampled at every 180 mm (i.e.
every 15th section) and mounted on super-frost plus slides. Sections
from the hypothalamus were sampled from the rostral part of the
hypothalamic PVN to the caudal part of the Arc. Sections from the
midbrain spanned the full rostro-caudal extension of the VTA and the
substantia nigra (SN). Sections were allowed to dry at room temper-
ature for an hour and then kept at 80 C until hybridization was
carried out.en access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 297
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In situ hybridizations (ISH) were performed using 33P-labeled RNA
probes according to previously described procedures [24,25]. Ribop-
robes were directed against rat cDNAs of neuropeptide Y (NPY, bp57-
404, GenBank accession number M20373), agouti-related peptide
(AgRP, alternative splice variant, GenBank accession number U89486),
proopiomelanocortin (POMC, bp162-626, GenBank accession number
J00759), cocaine-and-amphetamine-regulated transcript (CART,
bp226e411; GenBank accession number U10071), melanin-
concentrating hormone (MCH, bp45-440, GenBank accession num-
ber M29712), tyrosine hydroxylase (TH, bp14-1165, GenBank acces-
sion number M10244) and dopamine transporter (DAT, bp1406-1805,
GenBank accession number M80570). Anti-sense probes were
generated by in vitro transcription from the linearized plasmid DNA
containing the cDNA clones mentioned above.
Prior to ISH, sections were ﬁxated in 4% PFA for 5 min, rinsed 2 times
in phosphate buffered saline and acetylated in triethanolamine (0.1 M),
rinsed again and rehydrated through an ethanol gradient from absolute
ethanol to water. A viscous hybridization mixture containing the RNA
probe was added to the dry sections (80 ml per slide) after which the
sections were cover-slipped. Hybridization was carried out in a sealed
polypropylene box at 47 C and 100% relative humidity over-night.
Post-hybridization washes were performed at 62 C and 67 C in
50% formamide (1 h at each temperature). Finally, single stranded
RNA was removed by RNAse digestion (30 min at 45 C). After hy-
bridization, sections were exposed to autoradiographic ﬁlms, exposed
for 1e7 days depending on the individual probe and subsequently
developed in Kodak D19 developer.
The hybridization signals were evaluated using VIS image analysis
software (Visiopharm, Denmark) on high-resolution scanned ﬁlms. The
area under examination was delineated by a region of interest (ROI) in
the software, and the signals were quantiﬁed as the product of
intensiﬁed area and mean pixel intensity. Local background subtrac-
tion method was applied.
2.7. Statistics
Graphical presentations, calculations and statistical analyses were
carried out using GraphPad software (GraphPad Prism version 5, San
Diego, California, USA). Statistical analysis was performed using either
two-way analysis of variance (ANOVA) followed by Bonferroni’s post-hoc
test, or student’s unpaired t-test (p< 0.05 was considered signiﬁcant).
Results are presented as mean  standard error of the mean (SEM).
3. RESULTS
3.1. RYGB reduces body weight and adiposity
After a short initial period of post-operative weight loss, sham rats
returned to normal weight gain for the remainder of the study period
(Figure 1A). In contrast, animals undergoing gastric bypass surgery
showed a signiﬁcant reduction in terminal body weight
(441.6  16.0 g) compared with sham controls (522.2  18.9 g,
p < 0.01) (Figure 1A). When expressed as body weight change, RYGB
animals exhibited a maximal body weight loss of 16  2% (on post-
surgery day 16) compared to pre-surgical body weight, followed by
progressive weight regain resulting in a terminal body weight of
110  5% relative to day 1. In comparison, sham-operated rats
showed a terminal body weight of 153  5% relative to their pre-
surgical body weight (Figure 1B).
Body composition analysis by echo-MRI demonstrated a signiﬁcant
reduction in adiposity in RYGB animals compared with sham controls.
Hence, RYGB animals had a signiﬁcant lower terminal fat mass than298 MOLECULAR METABOLISM 5 (2016) 296e304  2016 The Authors. Published by Elsevier GmbH. Tsham operated animals (RYGB: 39.7  5.4 g; sham: 98.2  3.5 g,
p < 0.001). Lean mass was similar in the two experimental groups
(Figure 1C).
3.2. RYGB induces a change in food preference
Throughout the study, sham animals had a stable intake of both chow
and HPHF diet exhibiting a strong preference for the HPHF diet
(Figure 1D,E). After an initial post-operative recovery period, RYGB ani-
mals increased their food intake of both chow and HPHF diet, but with an
augmented preference for chow relative to sham throughout the study
period (Figure 1D). On day of termination (post-surgery day 60), RYGB
animals showed a signiﬁcantly lowered intake of HPHF diet relative to
sham animals (p< 0.05, student’s unpaired t-test). Except for the initial
post-surgery period (day 1e16), the total energy intake was comparable
between sham and gastric bypass operated animals (Figure 1F).
3.3. Upregulation of orexigenic signals in Arc but not lateral
hypothalamus after RYGB
To investigate potential changes in homeostatic control of energy
balance, we performed semi-quantitative mRNA in situ hybridizations
of selected neuropeptides in the hypothalamus. Representative images
of these hybridizations are shown in Figure 2.
As expected, 48 h food restriction in DIO rats led to a signiﬁcant upre-
gulation in mRNA expression of the orexigenic AgRP (43  7%,
p< 0.001 vs. free-fed animals) and NPY (44 12%, p< 0.01 vs. free-
fed animals) (Figure 3A,B). An even stronger response was observed in
RYGB animals showing an almost doubling in mRNA levels of both AgRP
(97 16%, p< 0.001 vs. sham-operated controls) and NPY (95 32%,
p < 0.05 vs. sham-operated controls). In contrast, expression of the
anorexigenic POMC and CART were unregulated in both RYGB and food
restricted animals as compared to their respective controls (Figure 3C,D).
POMC is expressed in both Arc and median eminence (see Figure 2),
however, mRNA levels were only quantiﬁed in the Arc.
To further assess downstream signaling from the Arc, we quantiﬁed
mRNA levels of the orexigenic MCH in the LHA. MCH mRNA expression
was signiﬁcantly higher in food restricted animals as compared to free-
fed animals (32  9%, p < 0.05), whereas MCH expression was
unaltered following RYGB surgery (p > 0.05 vs. sham-operated con-
trols) (Figure 3E).
The overall ﬁndings of hypothalamic gene expression in both food-
restricted and RYGB operated animals are illustrated in Figure 4.
Orexigenic signaling cascades are stimulated in animals following food
restriction (Figure 4A) but blunted in RYGB animals at the level of the
LHA (Figure 4B).
3.4. RYGB causes selective reduction in dopaminergic turnover
Due to the change in food preference repeatedly reported in RYGB
studies, we looked at marker genes for dopaminergic signaling in the
midbrain. Representative images of dopamine transporter (DAT) and
tyrosine hydroxylase (TH) mRNA in situ hybridization are shown in
Figure 5A. Quantiﬁcation of the mRNA levels of DAT and TH demon-
strated a downregulation in the VTA whereas no regulation was
observed in the SN. In RYGB operated animals in the VTA, DAT mRNA
was signiﬁcantly downregulated by 14  4% (p < 0.05) and TH
expression showed a tendency for downregulation (15  4%,
p ¼ 0.06) (Figure 5B,C).
4. DISCUSSION
In a rat model of RYGB surgery, we have examined whether changes in
body weight and food preference may be related to transcriptionalhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1: Body weight and food intake in RYGB and SHAM animals. RYGB surgery led to a sustained decreased in body weight relative to sham (A þ B) as well as a signiﬁcant
reduction in body fat mass (C). RYGB induced a persistent signiﬁcant increase in chow intake (D) whereas Gubra diet intake (E) and total energy intake (F) were similar between
sham and RYGB after an initial recovery period. Data are presented as mean  SEM; two-way ANOVA with Bonferroni post hoc test; *p < 0.05, **p < 0.01, ***p < 0.001. On the
day of euthanization (day 60) the intake of Gubra diet was signiﬁcantly reduced in the RYGB group (E); student’s unpaired t-test (*)p < 0.05.changes in key anorexigenic and orexigenic neuronal populations in
the hypothalamus. Our results show that arcuate levels of orexigenic
NPY and AgRP mRNAs are signiﬁcantly upregulated in RYGB rats
compared with sham animals to a similar degree as is observed in
food-restricted animals. In contrast, second-order downstream orexi-
genic MCH mRNA expression in the LHA is blunted in RYGB rats,
potentially related to a reduced mesolimbic dopaminergic
neurotransmission.
4.1. Increased hunger signaling in the Arc following RYGB
Due to the speciﬁc interest in central appetite regulation, primary focus
was directed towards the well-characterized hypothalamic Arc, which
is known to harbor speciﬁc cell groups responsive to metabolic re-
strictions [26]. Both NPY/AgRP and POMC/CART expressing neurons
are metabolic sensors whose activity is altered by feeding status,
glucose, long chain fatty acids, leptin and insulin (for review see [27]).
Interestingly, our data demonstrate that orexigenic NPY and AgRP
mRNAs were signiﬁcantly upregulated in rats at 60 days after RYGBMOLECULAR METABOLISM 5 (2016) 296e304  2016 The Authors. Published by Elsevier GmbH. This is an op
www.molecularmetabolism.comsurgery. In contrast, POMC/CART expression was unaltered in the Arc,
indicating a selective activation in hunger associated circuits. An
upregulation of arcuate AgRP and NPY transcription with unchanged
POMC expression has also been reported in rat models of bil-
iopancreatic and duodenal-jejunal bypass surgery [15,16]. However,
Romanova et al. demonstrated that immunohistochemically detectable
NPY was decreased in the Arc and in the PVN 10 days after RYGB
surgery in rats, as well as in pair fed controls compared with sham
surgery [28]. These data partly contradict our ﬁndings but may be
related to differences in study periods (i.e. an acute vs. a chronic
setting) or differences in transcriptional processing. Accordingly, the
reduction in NPY peptide levels in both RYGB and pair fed animals may
be a result of NPY depletion supporting increased activity of NPY
signaling.
In addition, Grayson et al. recently reported that vertical sleeve gas-
trectomy induces hypothalamic AgRP but not POMC expression in the
rat, implying that different experimental bariatric surgery procedures
may result in similar transcriptional regulations of orexigenic signalingen access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 299
Figure 2: Hypothalamic in situ hybridization micrographs. Representative photomicrographs of radioactive in situ mRNA hybridization in sham and RYGB operated animals as
well as in fed and fasted animals.
Original articlemarkers in the Arc [29]. In comparison to vertical sleeve gastrectomy, a
rat model of RYGB did not show altered AgRP expression [29]. In
contrast to the unbiased and systematic section sampling and in situ
hybridization procedure employed in the present study, the study byFigure 3: Quantiﬁcation of hypothalamic gene expression. RYGB surgery led to a signiﬁ
increase was seen in fasted animals compared with fed animals. No regulation in expressio
in mildly fasted animals (C þ D). MCH was signiﬁcantly upregulated in the lateral hypoth
presented as mean  SEM; student’s unpaired t-test; * compares RYGB to sham, c^ompa
300 MOLECULAR METABOLISM 5 (2016) 296e304  2016 The Authors. Published by Elsevier GmbH. TGrayson et al. analyzed gene expression in hypothalamic tissue ho-
mogenates, which could have precluded sufﬁcient structural resolution
and assay sensitivity. Furthermore, it should be noted that AgRP levels
cycles diurnally, and that the time of euthanization might inﬂuence thecant increase in mRNA levels of the orexigenic peptides AgRP (A) and NPY (B); a similar
n of the anorectic peptides CART and POMC was observed in neither RYGB surgery nor
alamus in fasted animals, but no change was observed in RYGB animals (E). Data are
res fasted to fed; *p < 0.05, **p < 0.01, ***p < 0.001.
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 4: Hypothalamic orexigenic signals in food restricted and RYGB animals. In 48 h mildly food restricted rats, elevated NPY and AgRP expression in the Arc leads to an
increase in MCH expression in the LHA compared with as lib fed rats (A). In RYGB operated animals the orexigenic signal from the Arc is blunted leading to unregulated MCH
expression relative to sham animals (B).
Figure 5: Quantiﬁcation of midbrain gene expression. Representative photomicrographs of radioactive in situ mRNA hybridization in sham and RYGB operated animals in the
midbrain (A). RYGB surgery led to a reduction in DAT and TH mRNA levels in the ventral tegmental area, whereas no changes were observed in the substantia nigra (B þ C). Data
are presented as mean  SEM; student’s unpaired t-test; *p < 0.05.
MOLECULAR METABOLISM 5 (2016) 296e304  2016 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 6: Reduced dopaminergic transmission in the mesolimbic pathway may
overrule orexigenic signals from the arcuate nucleus. We hypothesize that the
downregulated dopaminergic signaling in the mesolimbic pathway in rats following
RYGB surgery may lead to an increased inhibitory GABAergic output from the NAc shell,
which consequently overrules the stimulated orexigenic pathway from the Arc to the
LHA.
Original articleAgRP mRNA levels [30,31]. In the present study, however, all animals
were euthanized 2e3 h after light onset ensuring consistency between
groups.
4.2. Downstream signaling
The observation of elevated levels of Arc orexigenic transcription
markers is at odds with the ﬁnding that the RYGB rats showed no
overall increase in energy intake, compared to sham controls. We
therefore investigated MCH mRNA expression in the LHA, as MCH-
positive neurons in the LHA are strategically positioned to directly or
indirectly receive input (like leptin) that relate peripheral energy bal-
ance to the CNS. Indeed, MCH neurons in the LHA receive innervation
from NPY/AgRP and POMC neurons supporting that the MCH system is
downstream of the leptin responsive arcuate neurons [32]. Further-
more, LHA MCH expression is sensitive to changes in nutritional status,
as acute food deprivation, acute pharmacological glucose deprivation
and acute insulin-induced hypoglycemia all increase MCH mRNA
expression [33,34]. Taken together these data supports that MCH
release is stimulated by NPY whereas POMC inhibits its release (as
indicated in Figure 4A). The upregulated expression of MCH mRNA in
food restricted rats in the present study is in agreement with the
current understanding that MCH in the LHA acts as a downstream
mediator of NPY signaling [12]. Interestingly, however, MCH expres-
sion was unregulated in RYGB animals compared to sham, suggesting
that another extra-hypothalamic component is able to overrule the
hunger signals from the Arc.
4.3. Changes in mesolimbic dopaminergic gene expression
Besides a role in the homeostatic regulation of feeding behavior, the
LHA is also known as an integrative center of hedonic signaling. It
has been shown previously that dopaminergic signaling through the
mesolimbic pathway elevates the motivation to work for food,
particularly energy dense food, and thereby increases food intake
despite no obvious homeostatic requirement [18,35]. Our in situ
hybridization data for TH (the rate limiting enzyme in dopamine
biosynthesis) and DAT (the enzyme responsible for dopamine re-
uptake) demonstrate a reduction in mRNA levels in the VTA but not
in the SN, indicating that RYGB could lead to changes in dopami-
nergic turnover in the mesolimbic pathway. Based on these ﬁndings
we hypothesized, that downregulated signaling through this
pathway in rats following RYGB surgery may lead to an increased
inhibitory GABAergic output from the NAc shell which consequently
overrule the stimulated orexigenic pathway from the Arc to the LHA
(see Figure 6). This hypothesis is supported by the reciprocal and
functional connections documented between the NAc shell and MCH
neurons in the LHA [36,37] and that temporary inactivation of the
LHA is able to block the increased food intake induced by a GABA
agonist [38]. Even though additional studies are needed in order to
support our hypothesis, potential alterations in dopaminergic
signaling after surgery may explain not only the blunted NPY
induced hyperphagia but also the mechanisms behind the observed
changes in food preference with an increased preference for chow.
Alterations in dopaminergic signaling after RYGB have been reported
by others, with reduced neural responsivity to food cues in the
mesolimbic pathway [39] and alteration in dopamine receptor
availability in the striatum [40]. Similarly, a RYGB induced shift in
food preference towards low-calorie foods is now consistently re-
ported in studies from both animal models and man [19,20,41]
supporting further an involvement of the hedonic system in the
beneﬁcial effects of the RYGB surgery.302 MOLECULAR METABOLISM 5 (2016) 296e304  2016 The Authors. Published by Elsevier GmbH. T4.4. Gutebrain interaction
The observation that RYGB also induces resolution of T2DM prior to the
occurrence of weight loss indicates that the mechanism of action
might involve endocrine effects [42]. The re-routing of salivary se-
cretions and meals directly into the jejunum stimulate the release of
gut hormones which may affect glucose homeostasis and provide
signal to central appetite systems [43]. A series of papers have
conclusively validated that RYGB increases the secretion of gut-derived
peptides such as GLP-1 and PYY, while e.g. ghrelin is reduced [6e9].
These peptides are all part of the gutebrain axis with receptors located
in the periphery as well as in the CNS [44e46] and all play important
roles in satiety signaling in the brain [47,48]. Recently, it was shown
that peripheral administration of the GLP-1 receptor analog, liraglutide,
gains access to the hypothalamus with the body weight lowering ef-
fects being, at least partly, dependent on increased CART expression in
the Arc [49]. Moreover, both liraglutide and the DPP-IV inhibitor,
linagliptin, have been shown to alter food preference from a highly
palatable diet towards chow [22,50]. In the present study, RYGB did
not alter the expression of satiety-associated POMC/CART mRNAs in
the hypothalamus suggesting that the body weight lowering effects ofhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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RYGB surgery is not directly related to GLP-1 effects in the Arc.
Actually, the orexigenic tone in the Arc observed in the present study
indicates that this speciﬁc area is not primarily responsible for the
effects on food intake and body weight. On the contrary, several of the
gut-derived hormones that are altered after RYGB (e.g. ghrelin, GLP-1
and PYY) have receptors in the LHA and may reach these through
circulation and blood barrier transport, or by neural pathways such as
vagal afferent connections from the brainstem nucleus of the solitary
tract [51,52]. Whether these gut-derived hormones may be able to
blunt the NPY-MCH signaling pathway and prevent overeating in RYGB
operated animals is still not known. More data are also needed to
address whether increased gutebrain signaling could be involved in
modulating the expression of mesolimbic dopaminergic marker genes
after RYGB.
4.5. Conclusion
In conclusion, we show that arcuate levels of orexigenic NPY and AgRP
mRNAs are signiﬁcantly upregulated in RYGB rats indicating that
classical hunger signaling pathways are activated. In contrast, second-
order downstream orexigenic signals in the LHA (MCH neurons) are
blunted in RYGB rats suggesting that the hunger-signals arising from
the Arc do not translate into sensations of hunger nor into food-seeking
behavior. Simultaneously, RYGB leads to alterations in mid- and
forebrain hedonic signaling that can potentially be involved in the
modulation of appetite and body-weight in this model.
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